Literature DB >> 21700604

Preschool asthma after bronchiolitis in infancy.

P Koponen1, M Helminen, M Paassilta, T Luukkaala, M Korppi.   

Abstract

Asthma risk is lower after wheezing associated with respiratory syncytial virus (RSV) than with non-RSV infection in infancy. RSV is the main wheezing-associated virus in infants aged <6 months. We evaluated the outcome of children hospitalised for bronchiolitis at <6 months of age, with special focus on viral aetiology and early risk factors. Out of 205 infants hospitalised for bronchiolitis at <6 months of age, 127 (62%) attended a control visit at a mean age of 6.5 yrs and the parents of an additional 39 children were interviewed by telephone. Thus, follow-up data collected by identical structured questionnaires were available from 166 (81%) children. Viral aetiology of bronchiolitis, studied on admission by antigen detection or PCR, was demonstrable in 97% of cases. Current asthma was present in 21 (12.7%) children: 8.2% in the 110 former RSV patients versus 24% in non-RSV patients (p=0.01). 45 (27%) children had ever had asthma. In adjusted analyses, atopic dermatitis, non-RSV bronchiolitis and maternal asthma were independently significant early-life risk factors for asthma. The risk of asthma was lower after RSV bronchiolitis than after bronchiolitis caused by other viruses in children hospitalised at <6 months of age.

Entities:  

Mesh:

Year:  2011        PMID: 21700604     DOI: 10.1183/09031936.00040211

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  32 in total

1.  Environmental factors association between asthma and acute bronchiolitis in young children--a perspective cohort study.

Authors:  Hui-Wen Lin; Sheng-Chieh Lin
Journal:  Eur J Pediatr       Date:  2012-07-10       Impact factor: 3.183

2.  Determinants of asthma after severe respiratory syncytial virus bronchiolitis.

Authors:  Leonard B Bacharier; Rebecca Cohen; Toni Schweiger; Huiquing Yin-Declue; Chandrika Christie; Jie Zheng; Kenneth B Schechtman; Robert C Strunk; Mario Castro
Journal:  J Allergy Clin Immunol       Date:  2012-03-22       Impact factor: 10.793

3.  CD38 modulates respiratory syncytial virus-driven proinflammatory processes in human monocyte-derived dendritic cells.

Authors:  Ilaria Schiavoni; Carolina Scagnolari; Alberto L Horenstein; Pasqualina Leone; Alessandra Pierangeli; Fabio Malavasi; Clara M Ausiello; Giorgio Fedele
Journal:  Immunology       Date:  2017-12-18       Impact factor: 7.397

Review 4.  The role of early life viral bronchiolitis in the inception of asthma.

Authors:  Avraham Beigelman; Leonard B Bacharier
Journal:  Curr Opin Allergy Clin Immunol       Date:  2013-04

5.  Factors Associated With Asthma Diagnosis Within Five Years of a Bronchiolitis Hospitalization: A Retrospective Cohort Study in a High Asthma Prevalence Population.

Authors:  Amanda J Clark; Nancy Dong; Talia Roth; Lindsey C Douglas
Journal:  Hosp Pediatr       Date:  2019-10

6.  Bronchiolitis in young infants: is it a risk factor for recurrent wheezing in childhood?

Authors:  Firas Rinawi; Imad Kassis; Rina Tamir; Amir Kugelman; Isaac Srugo; Dan Miron
Journal:  World J Pediatr       Date:  2016-09-15       Impact factor: 2.764

Review 7.  Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens.

Authors:  Michael J Holtzman
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

8.  Interleukin 1 receptor-like 1 rs13408661/13431828 polymorphism is associated with persistent post-bronchiolitis asthma at school age.

Authors:  Riikka Riikonen; Johanna Teräsjärvi; Eero Lauhkonen; Kirsi Nuolivirta; Qiushui He; Matti Korppi
Journal:  Acta Paediatr       Date:  2021-11-18       Impact factor: 4.056

Review 9.  Viral infections and the development of asthma in children.

Authors:  Sejal Saglani
Journal:  Ther Adv Infect Dis       Date:  2013-08

Review 10.  A systematic review of predictive models for asthma development in children.

Authors:  Gang Luo; Flory L Nkoy; Bryan L Stone; Darell Schmick; Michael D Johnson
Journal:  BMC Med Inform Decis Mak       Date:  2015-11-28       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.